Latest Conference Articles

A new study presented at the 2012 Annual Meeting of the American Academy of Neurology suggests that the drug florbetaben can be used as a biomarker with positron emission tomography (PET) imaging to diagnose AD by detecting amyloid plaques in the brains of living people suspected of having AD.

Those who treat autoimmune diseases such as MS, much has been expected from stem cell research, and an ongoing study at the University of Cambridge, UK, has become a focus of high hopes.

Patients with MS and their physicians have long been aware that the risk of acquiring the disease is higher when there is a history of MS in the family.

This year's Constorium of Multiple Sclerosis Centers Annual Meeting is being hosted in San Diego known for its fresh seafood and wines. Here are some recommendations of restaurants to dine-in.

HCPLive will be providing live coverage from the 2012 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting in cooperation with Americans Committe for Treatment and Research in Multiple Sclerosis (ACTRIMS). Here are some of the highlights to look forward to during the meeting.

Dr. Sacco highlights some of the key takeaway points that he will speaking about during the Robert Wartenberg Lecture at this year's AAN Annual Meeting. He also discusses his involvement in the Northern Manhattan Study, which evaluates stroke in African and Hispanic Americans.

In this interview, Michael Zigmond, PhD, previews his lecture to be given at this year's AAN Annual Meeting. Zigmond explains how he became involved with studying Parkinson's disease (PD), research with exercise and PD, and what his intentions are with helping to fight this disease.

Bryn Vartabedian, MD, offers valuable tips and advice for health care providers who are interested in using social media to engage with and educate their patients.

Renee P. McLeod, PhD, APRN, CPNP, reviewed evidence-based recommendations on skin care in infants and other dermatological topics for pediatric nurse practitioners and parents.

Check out this slideshow for a look at the 33rd Annual Pediatric Health Care conference, held this year in San Antonio, TX, which provided health care professionals, industry representatives, and pediatric nurse practitioners with the latest updates in pediatric health care

Cognitive behavioral therapy, mindfulness, and breathing techniques are among several nonpharmaceutical interventions that have been shown to help children with anxiety. Rebecca Kajander, MPH, BSN, CPNP, PMHS, discussed these and other techniques that providers can use as part of effective therapy.

There are several factors that determine whether children with psychiatric disorders and their families decide to use psychotropic drugs as part of treatment. The patient-provider relationship is a key factor in promoting treatment adherence in this patient population, and there are several strategies that providers can use to improve this relationship and help ensure successful treatment.

William Atkinson, MD, delivered a wide-ranging look at recent developments in immunization research and policy, reviewed new recommendations for 2012, and offered several predictions on likely developments in the near future.

Bullying is on everyone's mind these days. Over the past two weeks, the media has strongly focuses on the trial of Dharun Ravi, the Rutgers University student recently convicted of 15 counts, including a hate crime and anti-gay intimidation of Tyler Clementi, his former roommate who committed suicide in September 2010.

Dr. Judith Palfrey challenged everyone to imagine what a nation of health kids would be like in the opening session of the 2012 NAPNAP Conference. The issue is, she stated, "You can't get any place if you don't know where you are going; try it."

According to a report from the HHS, pediatric rheumatology is not represented among 30-40% of US medical schools and pediatric residency programs and, perhaps even more alarming, the report found that 13 states lack a single pediatric rheumatologist.

HCPLive is offering live coverage from the 33rd Annual Conference on Pediatric Health Care which is providing health care professionals with the latest updates in pediatric health care.

At this year's AAN Annual Meeting, attendees will find exciting ways to explore New Orleans and can take advantage of the various downtime activities hosted by the AAN such as morning yoga or tennis.

This year's American Academy of Neurology Annual Meeting is being hosted in New Orleans, LA from April 21-27, which is known for its ecletic cuisine. Here are some ideas of restaurants to check out.

At this year's meeting, the AAN will be hosting various scientific and plenary session focusing on the hot topics in neurology.

Dr. Jean-Paul Achker said there is room for improvement of response rates with current treatment approaches. "There may be a limited window of time to maximize anti-TNFα therapy, as evidenced by the observed loss of response over time, the need to increase the dose of anti-TNFα therapy, and immunogenicity," he said.

K.V. Narayanan Menon, MD, talks about Cleveland Clinic's patients with liver cancer.

"IL-28B receptor polymorphism is an important predictor of SVR in patients treated with pegylated interferon and ribavirin," said Binu John, MD at the Cleveland Clinic.

Ahmed Kandiel, MD, MPH, at the Cleveland Clinic concluded his lecture, "Which Patient/Which Biologic," by reviewing the results of a recently published meta-analysis which examined the risks and benefits of biologic therapy for patients with moderate-to-severe IBD.

Ahmed Kandiel, MD, MPH, kicked off the 47th Annual Gastroenterology Update with a thorough review of the current treatment landscape for moderate to severe inflammatory bowel disease, including the potential risks for side effects for each biologic agent.

Bret Lashner, MD, MPH, FACG, shares his thoughts about the first day of the 47th Annual Gastroenterology Update at the Cleveland Clinic, including the recent developments with inflammatory bowel disease and hepatitis C therapy.

"The small number of patients that go on to develop chronic rhinosinusitis accumulates to about 15% of the population, making it an important disease," said Dr. Michael A. Kaliner during his lecture on chronic rhinosinusitis.

Although categorizing chronic rhinosinusitis is complex, CRS with or without nasal polyps is one way to initially begin classification. Prolonged duration of RS symptoms (>8-12 weeks) is the primary reason to evaluate patients for CRS. Dr. Meltzer emphasized the need to differentiate CRS from recurrent episodes of ARS.

During his lecture, Dr. Eli O. Meltzer walked his audience through diagnosis and management guidelines of sinusitis/ rhinosinusitis at the ACAAI annual meeting.

There are conflicting data regarding whether vitamin D deficiency is a risk factor for asthma. Observational studies have linked low vit D status with impaired lung capacity, increased airway hyperresponsiveness, corticosteroid unresponsiveness, relatively poor asthma control, and higher rates of asthma-related hospitalization.